• 검색 결과가 없습니다.

The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease.

N/A
N/A
Protected

Academic year: 2021

Share "The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease."

Copied!
7
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 2.  Twenty-Four Hour-Ambulatory Blood Pressure Monitoring (ABPM) and Central Hemodynamics Assessed with Noninvasive Tonometry
Fig. 1.  Coronary artery disease (CAD) severity according to the etiology  of end-stage renal disease (ESRD)

참조

관련 문서

The median concentrations of FDP were significantly elevated ( p= 0.02) and the median concentrations of fibronogen were decreased ( p= 0.021) in abnormal bleeding patients

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new‑onset type 2

Keywords: Trabecular bone score, End stage renal disease, Hemodialysis, Chronic kidney disease-mineral and bone disorder, Fracture, Cardiovascular

Among the various pulmonary manifestations, interstitial lung disease (ILD) is known to be associated with substantial morbidity and mortality rates in RA patients.. As RA-ILD

Although screening or prediction of many medical conditions can benefit public health, early identification of in- dividuals at risk for type 2 diabetes mellitus (DM) and

Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR

UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complcaitons in patients with